[an error occurred while processing this directive] |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Viral pneumoniasMultifaceted approach to an elusive diagnosisJason W. Chien, MD; John L. Johnson, MD VOL 107 / NO 1 / JANUARY 2000 / POSTGRADUATE MEDICINE
CME learning objectives
Preview: Determining whether a patient has viral pneumonia can be tricky. Even when a virus is isolated, it may not be the cause of the pneumonia. Here, Drs Chien and Johnson discuss the means of making this elusive diagnosis with confidence. Part 2 and Part 3 of this three-part article, which focus on viral pneumonia in the immunocompromised host and viral pneumonia due to epidemic respiratory viruses, will appear in our February and March issues.
Viral pneumonias have been reported with increasing frequency during the past decade. This increase is most likely due to a combination of more sensitive diagnostic techniques and the greater risk for viral pneumonias among the growing immunocompromised population. Several studies have shown that bacterial and viral pathogens are identified in 26% to 77% of cases of community-acquired pneumonia (1-3). Influenza A and B and parainfluenza viruses are the most common causes of respiratory illness among adults (4) (table 1).
Up to 50% of all pneumonias occurring in children under 3 years of age may have a viral origin (1). Among children, the most commonly identified pathogens are respiratory syncytial virus, parainfluenza viruses, and influenza viruses (4) (table 1). Faced with this growing population at risk for serious viral infections of the lower respiratory tract, clinicians need to understand the methods currently available for detecting respiratory viruses and be able to correlate clinical, radiographic, and laboratory findings to determine the causative role of recovered viruses in lower respiratory tract disease. Clinical diagnosis of viral pneumoniaBefore modern laboratory diagnostic tests were developed, viral pneumonia was diagnosed primarily on clinical grounds. This was often challenging because the clinical presentation of viral pneumonia varies and is often nonspecific. Suspicion of a viral cause of pneumonia in a patient should be based on a combination of epidemiologic, clinical, radiographic, and laboratory characteristics. Several epidemiologic characteristics suggest a viral infection. For instance, various viral pneumonias typically occur during specific times of the year, among closed populations, or in populations with underlying cardiopulmonary or immunocompromising disease (1,5). Clinical manifestations of viral pneumonia typically include constitutional symptoms such as fever, chills, nonproductive cough, rhinitis, myalgias, headaches, and fatigue. These symptoms, together with physical findings such as wheezing, rales, increased fremitus, and signs of widespread bronchial inflammation, often accompany viral infections of the lower respiratory tract. However, they are also seen in pyogenic pneumonia and are nonspecific. Characteristic rashes of measles or varicella or associated mucocutaneous lesions of herpes simplex infection are important diagnostic clues. Unfortunately, the radiographic features of viral pneumonia are also nonspecific and difficult to differentiate from those of bacterial pneumonia. Findings are often similar and can range from patchy bronchopneumonia to fleeting infiltrates to more characteristic diffuse interstitial infiltrates (figure 1: not shown). Cavitation and pleural effusions are rare. Laboratory diagnosis of viral pneumoniaDevelopments in diagnostic techniques have led to significant improvement in the ability to detect viruses in the respiratory tract. Laboratory methods can be categorized as cytologic evaluation, viral culture, rapid antigen detection, and gene amplification (table 2).
When using these highly sensitive and specific methods, one must realize that the detection of certain viral pathogens does not always suggest active disease. Herpesvirus, for example, can establish a lifelong latent infection that may become reactivated without causing significant active disease. Some viruses, such as respiratory syncytial virus and cytomegalovirus, can be detected in the presence of other bacterial pathogens, making it hard to decide which pathogen is the true causative agent. In these situations, histopathologic findings are critical to definitive diagnosis.
Cytologic evaluation
Viral culture Proper preservation of specimens for viral culture depends on the use of an appropriate transport medium. Transport media consist of enriched broth containing antibiotics and a protein substrate that protects the viruses and prevents bacterial or fungal overgrowth during transport. Once the specimens are obtained, they should be immediately placed in the viral transport medium, kept on ice or refrigerated, and transported quickly to the laboratory, where they are centrifuged and filtered to remove mucus and other debris. The supernatant or filtrate is then used for culture. Viral cultures are performed on various cell lines, such as monkey kidney cells or diploid fibroblasts. Cell cultures are incubated at 35°C and examined microscopically on alternate days during a predetermined incubation period (usually 14 days). Changes in appearance, called the viral cytopathogenic effect, are evidence of viral growth. The viral cytopathogenic effect is manifested as degenerative changes or the formation of syncytial collections of multinucleated giant cells. These changes are rarely virus-specific. Viral growth also can be detected by hemadsorption testing. The antigens of certain viruses, such as influenza and parainfluenza, have an affinity for erythrocytes. By adding guinea pig erythrocytes to cultured cell monolayers, the adherence of red blood cells to the cultured cell monolayer of infected tissue may be noted, demonstrating the presence of these viruses. When the cytopathogenic effect is observed or hemadsorption tests are positive, the responsible virus is identified by further testing. One common technique is immunofluorescence by direct or indirect methods; another is the use of nucleic acid probes. These techniques can be used to identify specific viruses such as influenza A and B, parainfluenza virus, adenoviruses, respiratory syncytial virus, herpes simplex virus, and cytomegalovirus in cell cultures. Modified cell culture methods, called shell vial culture systems, have been developed to detect viruses, such as cytomegalovirus, that grow very slowly in conventional fibroblast cell culture, often requiring 14 to 18 days to produce the cytopathogenic effect (6). With such systems, prepared clinical specimens are inoculated onto adherent cell monolayers grown on round coverslips in small vials. The vials are centrifuged at low speed for 1 hour, after which fresh culture medium is added. The vials are then incubated and examined serially to detect viral antigen or DNA expression. Shell vial culture systems are now widely used to speed the detection of cytomegalovirus, respiratory syncytial virus, herpes simplex virus, adenovirus, influenza virus, parainfluenza virus, and other pathogens.
Rapid antigen detection Antigen detection tests have several advantages. Unlike viral culture, they are specific for each virus. In addition, many laboratories use panels of antibodies to common respiratory viruses, thus permitting the screening of clinical specimens for many viruses at once. For instance, the respiratory antigen panel routinely includes influenza and parainfluenza viruses, adenovirus, and respiratory syncytial virus. In addition, antigen detection assays remain positive for several days to weeks after viable virus can no longer be detected in culture. This feature is useful in the evaluation of patients who present late after the onset of symptoms or patients who have received prior treatment with antiviral agents. The disadvantage of viral antigen detection methods is that, overall, their sensitivity is lower than that of viral cultures. Sensitivity also varies depending on the virus sought. For instance, the sensitivity of immunofluorescence assays is high for respiratory syncytial virus and influenza B virus (87% to 93%) but low for adenovirus and parainfluenza virus (51% to 67%) (6). It is always recommended, therefore, that antigen detection methods be used in conjunction with cell culture for optimal diagnosis of viral infections.
Gene amplification A recently developed molecular diagnostic technique, multiplex reverse transcriptase-PCR (MRT-PCR), overcomes the low sensitivity of antigen detection methods, the delay of viral cultures, and the limitation of assaying for only one virus at a time by traditional PCR (7). This technique permits rapid detection of respiratory syncytial virus, adenovirus, and parainfluenza virus types 1, 2, and 3 in appropriate respiratory tract secretions by using a single-step MRT-PCR with high sensitivity and specificity. SummaryDespite enhanced laboratory techniques such as viral culture, rapid antigen detection, and gene amplification, a confident diagnosis of viral pneumonia continues to be a challenge. The nonspecific nature of clinical characteristics and the extreme sensitivity of laboratory techniques make the diagnosis difficult, even when a viral agent is detected. Understanding the limitations of these technological advances and the use of histopathologic techniques can greatly enhance a skilled clinician's ability to make an accurate diagnosis. Part 2 and Part 3 of this article, which focus on viral pneumonia in the immunocompromised host and viral pneumonia due to epidemic respiratory viruses, respectively, will appear in our February and March issues.
References
Dr Chien has completed a fellowship in infectious diseases at Case Western Reserve University School of Medicine, Cleveland, and is now a fellow in the division of pulmonary and critical care medicine, University of Washington School of Medicine, Seattle. Dr Johnson is associate professor of medicine, division of infectious diseases, Case Western Reserve University School of Medicine. Correspondence: Jason W. Chien, MD, University of Washington School of Medicine, Division of Pulmonary and Critical Care Medicine, BB-1253 Health Sciences Center, UW Box 356522, Seattle, WA 98195-6522. E-mail: jasonc@u.washington.edu.
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
about us | cme | home | issue index | patient notes | pearls | ad services |
Please send technical questions related to the Web site to Ann Harste |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||